• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

MediciNova Inc

+ Add to Watchlist


3.7700 USD 0.1600 4.43%

As of 20:10:00 ET on 10/21/2014.

Snapshot for MediciNova Inc (MNOV)

Open: 3.6100 Day's Range: 3.4700 - 3.8500 Volume: 95,200
Previous Close: 3.6100 52wk Range: 1.6600 - 5.2500 1-Yr Rtn: +45.00%

Stock Chart for MNOV

No chart data available.
  • MNOV:US 3.7700
  • 1D
  • 1M
  • 1Y
Interactive MNOV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MNOV

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.1300
Est. EPS (USD) (12/2014) -0.3500
Est. PEG Ratio -
Market Cap (M USD) 91.03
Shares Outstanding (M) 24.15
30 Day Average Volume 210,123
Price/Book (mrq) 3.6708
Price/Sale (ttm) 13.5089
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MNOV

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MNOV

MediciNova, Inc. acquires, develops, and commercializes small molecule therapeutics. The Company, through alliances with Japanese pharmaceutical companies, has built a portfolio of drug candidates. MediciNova researches treatments for asthma, status asthmaticus, insomnia, interstitial cystitis, cancer, multiple sclerosis, preterm labor, urinary incontinence, and anxiety.

Yuichi IwakiPresident/CEO/FounderVan Den BoomChief Financial Officer
Kazuko MatsudaChief Medical OfficerMasatsune OkajimaVP/Head:Japanese Office
More Company Profile & Key Executives for MNOV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil